BioSpace News Archive

Drug Development

First patient dosed in the phase 2a part of Medivir’s study with fostrox in combination with Lenvima®

Medivir AB announced that the first patient with hepatocellular carcinoma has started treatment in phase 2a with the candidate drug fostroxacitabine bralpamide in combination with Lenvima®.

March 14, 2023
·
3 min read
Business

Philips and Gibraltar Health Authority announce 16-year strategic partnership, transforming patient imaging and cardiac care at St Bernard’s Hospital

Royal Philips, a global leader in health technology, and the Gibraltar Health Authority, announced they have signed a long-term strategic partnership continuing their long-standing relationship and marking ambitions to advance radiology and cardiology patient care.

March 14, 2023
·
4 min read
Drug Development

Patient Enrollment Completed for Phase III Clinical Trial of Akeso’s Cadonilimab in Treatment of Gastric Cancer

Akeso, Inc. announced that patient enrollment has been completed for its pivotal Phase III clinical trial for cadonilimab, the world’s first approved and marketed dual-immune checkpoint bi-specific antibody drug, for use in combination with chemotherapy as first-line therapy for advanced gastric or gastroesophageal junction cancer.

March 14, 2023
·
2 min read
Policy

Ellipses Pharma: EP0042 Receives Orphan Drug Designation from the US Food and Drug Administration

Ellipses Pharma announces that the U.S. Food and Drug Administration has granted Orphan Drug Designation to EP0042, a dual FLT-3 and Aurora kinase inhibitor, for the treatment of acute myeloid leukaemia.

March 14, 2023
·
5 min read
Business

So-Young to Report Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023

So-Young International Inc. announced that it will report its financial results for the fourth quarter and full year ended December 31, 2022, before U.S. markets open on March 21, 2023.

March 14, 2023
·
2 min read
Pharm Country

PMC Group International Announces Copperhead Chemical Company Inc. Receives Northrop Grumman Strategic Excellence Award

Copperhead Chemical Company Inc., a subsidiary of PMC Group International, earned Northrop Grumman’s 2022 Strategic Excellence Award as part of their Supplier Excellence Awards.

March 14, 2023
·
1 min read
Deals

ADAMA Acquiring the Remaining Stakes of its Bio Stimulants Business in Chile

ADAMA Ltd., a leading crop protection company, announced that it has exercised its call option to acquire the remaining 40% stake in ADAMA Chile, formerly known as Chile Agro.

March 14, 2023
·
2 min read
KronosMD Inc., A Subsidiary Of $KNOS, is Set To Disrupt The Multi-Billion-Dollar Medical Ultrasound Imaging Industry Via Acquisition Of a Manufacturing-Ready Patent Portfolio.

KronosMD, INC. announced today that it has successfully acquired all existing and future assets and intellectual property related to its upcoming innovative 3D ultrasound dental imaging and diagnostic devices.

March 14, 2023
·
9 min read
Business

CN Bio Appoints Deepak Singh as Vice President of Sales and Marketing

CN Bio, a leading Organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has today announced that is has appointed Deepak Singh as Vice President of Sales and Marketing.

March 14, 2023
·
3 min read
Business

Eyeganics Organic Tears, the Only USDA-Certified Organic Lubricant Eye Drop, Now Available through NovaBay Pharmaceuticals’ Avenova.com and Physician-Dispensed Channel

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces a partnership with Eyeganics to sell OTC Organic Tears (0.2% organic glycerin) on Avenova.com and through Avenova’s physician-dispensed channel.

March 14, 2023
·
4 min read